Understanding the Influence of Pregnancy on Breast Milk
Mom2Baby Pilot
Mom2Baby Pilot: Understanding the Influence of Pregnancy on Breast Milk
1 other identifier
observational
18
1 country
1
Brief Summary
The purpose of this study is to identify the influences of pregnancy on breast milk and the effects of these on the health of babies during the first 2 months of life. The investigators hypothesize that overweight and obese mothers will have lower serum n-3 to n-6 PUFA ratios during pregnancy and postpartum than normal weight mothers and will be positively correlated with TNF-α, IL-1β, resistin, and negatively correlated ghrelin levels both in serum and in breast milk in postpartum.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2015
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2014
CompletedFirst Posted
Study publicly available on registry
December 16, 2014
CompletedStudy Start
First participant enrolled
February 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedSeptember 23, 2020
September 1, 2020
10 months
December 8, 2014
September 21, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
serum levels of n-3 to n-6 PUFA ratios during pregnancy will be compared to inflammatory markers and regulatory markers in blood and breast milk in both groups
1-2 months postpartum
Secondary Outcomes (1)
energy intake and diet quality assessed compositely with the Remote Food Photography Method developed at Pennington Biomedical during pregnancy will be compared to energy intake and diet quality in postpartum in both groups.
1-2 months postpartum
Other Outcomes (1)
n-3 and n-6 PUFA levels and inflammatory markers in mother's blood and breast milk will be assessed to test correlations to infants' body composition
1-2 months postpartum
Study Arms (2)
Overweight/Obese
Archive blood, archive breast milk, and clinical assessment data from 15 participants who were considered overweight or obese at enrollment in the Expecting Success study conducted at Pennington Biomedical Research Center (NCT01610752) will be used to represent the overweight and obese sample for study investigations.
Normal Weight
Up to 20 pregnant women who were considered normal weight (18.5 ≤ BMI ≤ 24.9 kg/m2) prior to pregnancy will be enrolled in the study.
Eligibility Criteria
Up to 20 pregnant women who were considered normal weight (18.5 ≤ BMI ≤ 24.9 kg/m2) prior to pregnancy will be enrolled in the study. Archive blood, archive breast milk, and clinical assessment data from 15 participants who were considered overweight and obese at enrollment in the Expecting Success study conducted at Pennington Biomedical Research Center (NCT01610752) will be used to represent the overweight and obese sample.
You may qualify if:
- Female
- Pregnant (prior to 36 weeks gestation) with singleton viable pregnancy
- Not diagnosed with gestational diabetes in the 2nd trimester of current pregnancy as determined by 2nd trimester oral glucose tolerance test
- years of age
- Normal weight (18.5 ≤ BMI ≤ 24.9 kg/ m2) prior to pregnancy
- English speaking
- Willing to complete up to 3 clinic visits at Pennington Biomedical Research Center
- Willing to enroll infant in the study after infant is delivered
- Intend to breastfeed or provide breast milk to infant until the infant is at least 2 months of age
- Willing for study staff to contact the primary care doctor who is providing prenatal care for the current pregnancy and to obtain information from the prenatal medical records, the labor and delivery records and the medical records of the infant at birth
You may not qualify if:
- Recent history of or currently smoking
- Recent history of or current alcohol or drug abuse
- Not willing to complete up to 3 clinic visits at Pennington Biomedical Research Center
- Not willing to enroll infant in the study after infant is delivered
- Not planning on breastfeeding or providing breast milk to infant prior to 2 months of age
- Plans to move out of the study area within the study period
- Not willing to avoid pregnancy for 2 months following delivery
- Prior or planned (within 1 year of expected delivery) bariatric surgery
- Enrollment in this study in a previous pregnancy
- Known fetal anomaly in current pregnancy
- History of preterm birth
- Planned termination or adoption of infant from current pregnancy
- History of 3 or more consecutive first trimester miscarriages
- Hypertensive (SBP\>160 mmHg \& DBP \>110 mmHg)
- Diabetic diagnosis prior to pregnancy
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808, United States
Biospecimen
Maternal Blood Collection: approximately 60 mL of blood will be collected over 2 timepoints Breast Milk Collection: approximately 50-100 mL of breast milk will be collected at 1 timepoint Infant Stool Collection: 1 fresh infant stool sample will be collected at 1 timepoint
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Henry Nuss, Ph.D.
Louisiana State University Health Sciences Center in New Orleans
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 8, 2014
First Posted
December 16, 2014
Study Start
February 1, 2015
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
September 23, 2020
Record last verified: 2020-09